Vanda Pharmaceuticals (VNDA) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q3 2025 value amounting to -$0.38.
- Vanda Pharmaceuticals' EPS (Weighted Average and Diluted) fell 32222.22% to -$0.38 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.43, marking a year-over-year decrease of 39310.34%. This contributed to the annual value of -$0.33 for FY2024, which is 91256.65% down from last year.
- Latest data reveals that Vanda Pharmaceuticals reported EPS (Weighted Average and Diluted) of -$0.38 as of Q3 2025, which was down 32222.22% from -$0.46 recorded in Q2 2025.
- Over the past 5 years, Vanda Pharmaceuticals' EPS (Weighted Average and Diluted) peaked at $0.17 during Q2 2021, and registered a low of -$0.5 during Q1 2025.
- For the 5-year period, Vanda Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$0.05, with its median value being $0.0 (2023).
- As far as peak fluctuations go, Vanda Pharmaceuticals' EPS (Weighted Average and Diluted) surged by 140000.0% in 2021, and later tumbled by 297976.72% in 2024.
- Over the past 5 years, Vanda Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at $0.12 in 2021, then grew by 0.0% to $0.12 in 2022, then tumbled by 141.67% to -$0.05 in 2023, then tumbled by 68.95% to -$0.08 in 2024, then tumbled by 349.85% to -$0.38 in 2025.
- Its last three reported values are -$0.38 in Q3 2025, -$0.46 for Q2 2025, and -$0.5 during Q1 2025.